Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia.
Jae Seung ChungWon Ik SeoCheol Kyu OhSeong Cheol KimMyung Chan ParkSang Hyun ParkJihyeong YuChan Ho LeeWan Suk KimTae Yong ParkKweon Sik MinJae Il ChungPublished in: Investigative and clinical urology (2019)
In contrast with our expectations, the preoperative use of 5ARI increased the efficiency of thulium laser surgery for BPH. Thus, it may not be necessary to stop 5ARI treatment before performing thulium laser surgery in this setting.